These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 26187236)

  • 1. Acute skin toxicity management in head and neck cancer patients treated with radiotherapy and chemotherapy or EGFR inhibitors: Literature review and consensus.
    Russi EG; Moretto F; Rampino M; Benasso M; Bacigalupo A; De Sanctis V; Numico G; Bossi P; Buglione M; Lombardo A; Airoldi M; Merlano MC; Licitra L; Denaro N; Pergolizzi S; Pinto C; Bensadoun RJ; Girolomoni G; Langendijk JA
    Crit Rev Oncol Hematol; 2015 Oct; 96(1):167-82. PubMed ID: 26187236
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sepsis in head and neck cancer patients treated with chemotherapy and radiation: Literature review and consensus.
    Mirabile A; Numico G; Russi EG; Bossi P; Crippa F; Bacigalupo A; De Sanctis V; Musso S; Merlotti A; Ghi MG; Merlano MC; Licitra L; Moretto F; Denaro N; Caspiani O; Buglione M; Pergolizzi S; Cascio A; Bernier J; Raber-Durlacher J; Vermorken JB; Murphy B; Ranieri MV; Dellinger RP
    Crit Rev Oncol Hematol; 2015 Aug; 95(2):191-213. PubMed ID: 25818202
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dysphagia in head and neck cancer patients treated with radiotherapy and systemic therapies: Literature review and consensus.
    Schindler A; Denaro N; Russi EG; Pizzorni N; Bossi P; Merlotti A; Spadola Bissetti M; Numico G; Gava A; Orlandi E; Caspiani O; Buglione M; Alterio D; Bacigalupo A; De Sanctis V; Pavanato G; Ripamonti C; Merlano MC; Licitra L; Sanguineti G; Langendijk JA; Murphy B
    Crit Rev Oncol Hematol; 2015 Nov; 96(2):372-84. PubMed ID: 26141260
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral toxicity management in head and neck cancer patients treated with chemotherapy and radiation: Xerostomia and trismus (Part 2). Literature review and consensus statement.
    Buglione M; Cavagnini R; Di Rosario F; Maddalo M; Vassalli L; Grisanti S; Salgarello S; Orlandi E; Bossi P; Majorana A; Gastaldi G; Berruti A; Trippa F; Nicolai P; Barasch A; Russi EG; Raber-Durlacher J; Murphy B; Magrini SM
    Crit Rev Oncol Hematol; 2016 Jun; 102():47-54. PubMed ID: 27061883
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pain management in head and neck cancer patients undergoing chemo-radiotherapy: Clinical practical recommendations.
    Mirabile A; Airoldi M; Ripamonti C; Bolner A; Murphy B; Russi E; Numico G; Licitra L; Bossi P
    Crit Rev Oncol Hematol; 2016 Mar; 99():100-6. PubMed ID: 26712589
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oral toxicity management in head and neck cancer patients treated with chemotherapy and radiation: Dental pathologies and osteoradionecrosis (Part 1) literature review and consensus statement.
    Buglione M; Cavagnini R; Di Rosario F; Sottocornola L; Maddalo M; Vassalli L; Grisanti S; Salgarello S; Orlandi E; Paganelli C; Majorana A; Gastaldi G; Bossi P; Berruti A; Pavanato G; Nicolai P; Maroldi R; Barasch A; Russi EG; Raber-Durlacher J; Murphy B; Magrini SM
    Crit Rev Oncol Hematol; 2016 Jan; 97():131-42. PubMed ID: 26318095
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mucositis in head and neck cancer patients treated with radiotherapy and systemic therapies: Literature review and consensus statements.
    De Sanctis V; Bossi P; Sanguineti G; Trippa F; Ferrari D; Bacigalupo A; Ripamonti CI; Buglione M; Pergolizzi S; Langendjik JA; Murphy B; Raber-Durlacher J; Russi EG; Lalla RV
    Crit Rev Oncol Hematol; 2016 Apr; 100():147-66. PubMed ID: 26947812
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of radiodermatitis associated with cetuximab in squamous cell carcinomas of the head and neck.
    Villavicencio M; Granados-García M; Vilajosana E; Domínguez-Cherit J
    Int J Dermatol; 2017 Jun; 56(6):602-609. PubMed ID: 28247918
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Management of severe bio-radiation dermatitis induced by radiotherapy and cetuximab in patients with head and neck cancer: emphasizing the role of calcium alginate dressings.
    Bonomo P; Desideri I; Loi M; Ciccone LP; Lo Russo M; Becherini C; Greto D; Simontacchi G; Pimpinelli N; Livi L
    Support Care Cancer; 2019 Aug; 27(8):2957-2967. PubMed ID: 30569265
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Late toxicity after radical treatment for locally advanced head and neck cancer.
    Taberna M; Rullan AJ; Hierro C; Navarro V; Vázquez S; Lozano A; Vilajosana E; Maños M; Marí A; Viñals J; Mesía R
    Oral Oncol; 2015 Aug; 51(8):795-9. PubMed ID: 26051499
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Management of Skin Reactions During Cetuximab Treatment in Association With Chemotherapy or Radiotherapy: Update of the Italian Expert Recommendations.
    Pinto C; Barone CA; Girolomoni G; Russi EG; Merlano MC; Ferrari D; Maiello E
    Am J Clin Oncol; 2016 Aug; 39(4):407-15. PubMed ID: 27077276
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypericum perforatum and neem oil for the management of acute skin toxicity in head and neck cancer patients undergoing radiation or chemo-radiation: a single-arm prospective observational study.
    Franco P; Potenza I; Moretto F; Segantin M; Grosso M; Lombardo A; Taricco D; Vallario P; Filippi AR; Rampino M; Ricardi U
    Radiat Oncol; 2014 Dec; 9():297. PubMed ID: 25544371
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Severe radiation dermatitis in patients with locally advanced head and neck cancer treated with concurrent radiation and cetuximab.
    Koutcher LD; Wolden S; Lee N
    Am J Clin Oncol; 2009 Oct; 32(5):472-6. PubMed ID: 19487913
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of head and neck cancers: issues for clinical pharmacists.
    Scarpace SL; Brodzik FA; Mehdi S; Belgam R
    Pharmacotherapy; 2009 May; 29(5):578-92. PubMed ID: 19397465
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical recommendations for defining platinum unsuitable head and neck cancer patient populations on chemoradiotherapy: A literature review.
    Ahn MJ; D'Cruz A; Vermorken JB; Chen JP; Chitapanarux I; Dang HQ; Guminski A; Kannarunimit D; Lin TY; Ng WT; Park KU; Chan AT
    Oral Oncol; 2016 Feb; 53():10-6. PubMed ID: 26712252
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Feasibility and toxicity of concurrent chemoradiation for elderly patients with head and neck cancer.
    Daly ME; Lau DH; Farwell DG; Luu Q; Donald PJ; Chen AM
    Am J Otolaryngol; 2013; 34(6):631-5. PubMed ID: 23954137
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management of dermatitis in patients with locally advanced squamous cell carcinoma of the head and neck receiving cetuximab and radiotherapy.
    Cabezón-Gutiérrez L; Khosravi-Shahi P; Escobar-Álvarez Y
    Oral Oncol; 2012 Apr; 48(4):293-7. PubMed ID: 22137799
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevention and treatment of radiation-induced acute dermatitis in head and neck cancer patients: a systematic review.
    Iacovelli NA; Galaverni M; Cavallo A; Naimo S; Facchinetti N; Iotti C; Fallai C; Orlandi E
    Future Oncol; 2018 Feb; 14(3):291-305. PubMed ID: 29153015
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-EGFR therapies: clinical experience in colorectal, lung, and head and neck cancers.
    Vokes EE; Chu E
    Oncology (Williston Park); 2006 Apr; 20(5 Suppl 2):15-25. PubMed ID: 16736979
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Emerging perspectives in epidermal growth factor receptor targeting in head and neck cancer.
    Kim S; Grandis JR; Rinaldo A; Takes RP; Ferlito A
    Head Neck; 2008 May; 30(5):667-74. PubMed ID: 18383530
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.